Clinical Trial

Effect of Miralax NPO Time on Residual Gastric Volumes and Bowel Preparation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to assess differences in residual gastric volumes after stopping Miralax ingestion at different time points (2, 4, 6 hours) prior to anesthesia induction and compare it to the control (current institutional standard of care where no Miralax is given on the day of surgery).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-26.
Trial Details
NCT Number NCT07616908
Lead Sponsor Stanford University
Conditions Residual Gastric Contents, Polyethylene Glycol
Enrollment 200 participants
Start Date 2026-07
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-06